Get a head start on searching through ASCO abstracts with these 10 summaries.
ArQule recently reported a loss of 9 cents per share in the first quarter of 2013, narrower than the Zacks Consensus Estimate of a loss of 11 cents per share.
ArQule Management Discusses Q1 2013 Results - Earnings Call Transcript
ArQule, Inc. today announced its financial results for the first quarter of 2013.
ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsMay 8
ArQule, Inc. today announced that it will report its financial results for the first quarter of 2013 on Wednesday, May 8, 2013 at 7:00 a.m. Eastern Time. The Company will hold a conference call at 9:00 a.m.
ArQule, Inc. today announced that the Company will present at the Needham 12th Annual Healthcare Conference on Tuesday, April 30, 2013 at 10:40 a.m. The presentation
Researchers recently presented data on ArQule's ARQ 092 at the AACR Annual Meeting held in Washington, D.C. which revealed that the candidate inhibits the AKT pathway and proved to be quite safe in an ongoing phase I clinical trial.